Skip to main content
OpenTrials
Completed

NCT Number: NCT02874261

Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders including cardiovascular disease. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." The frequency of the translation (up to 180 cycles/minute; cpm) as well as the distance traveled (2-24mm) by the bed can be adjusted by the patient or health care professional.

The science behind the therapeutic effects of WBPA still remains largely unknown.

The investigators are observing how WBPA may impact on sleep and activity in individuals with Parkinson's disease.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NYIT

Old Westbury, New York, 11568568, United States

About this study

Sleep disturbances are common in individuals with Parkinson's Disease. Whole-body periodic acceleration (WBPA) is a new, non-invasive, and promising therapy for a diverse and growing list of disorders. During WBPA, patients lie in the supine position on a bed that is capable of translating back and forth parallel to the ground, along the head-to-foot axis of the patient. Thus, this treatment is best described as a form of "passive exercise." WBPA has been shown in previous studies to increase nitric oxide. Increased levels of nitric oxide have been shown to improve sleep patterns in other populations. The current pilot study will investigate how WBPA will impact upon sleep disturbances in subjects with Parkinson's disease who suffer from abnormal sleep patterns. The investigators will record sleep patterns and activity levels using a Jawbone U3® activity monitor.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy individuals between the ages of 50-80
  • Individuals with Parkinsons disease between the ages of 50-80
  • Individuals with a smart phone

Exclusion criteria

  • Any condition that prevents you from lying flat on your back, any other neurological condition than Parkinson's disease.

Treatment and study plan

Whole Body Periodic Acceleration

Device

oscillating bed that the subject will lie on 3 days a week for 45 minutes at 140 cycles per minute.

Other names: WBPA

Primary outcomes

  1. Sleep patterns using an activity monitor on the wrist

    Time frame: 6 weeks

    The investigators will record sleep patterns a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

Secondary outcomes

  1. Pittsburgh Sleep Quality Index

    Time frame: 6 weeks

    This is a quantitative tool to measure sleep as well as an activity monitor twenty -four hours for seven days at a time

  2. Physical Activity (steps per day using an activity monitor on the wrist)

    Time frame: 6 weeks

    The investigators will record steps per day a week before WBPA through out the 4 weeks of WBPA and then one week post WBPA using an activity monitor on the wrist

Sponsors and collaborators

Lead sponsor

New York Institute of Technology

Other

Registry information

Official study title

Effects of Whole Body Periodic Acceleration on Activity and Sleep In Parkinson's Disease

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Aug 22, 2016
Registry last updated
Oct 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.